PT Itama Ranoraya Tbk (ISX:IRRA) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:IRRA PT Itama Ranoraya Tbk ISX:IRRA
84 GF Score
Price Rp372.00
GF Value Rp446.71
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is PT Itama Ranoraya Tbk Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of PT Itama Ranoraya Tbk is: Moderate Risk: Sensitive, better choose undervalued stock.

PT Itama Ranoraya Tbk  (ISX:IRRA) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

PT Itama Ranoraya Tbk Risk Assessment Related Terms

ISX:IRRA vs MCK, COR, CAH: Risk Assessment Comparison

For the Medical Distribution subindustry, PT Itama Ranoraya Tbk's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Itama Ranoraya Tbk Risk Assessment vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Itama Ranoraya Tbk's Risk Assessment distribution charts can be found below:

* The bar in red indicates where PT Itama Ranoraya Tbk's Risk Assessment falls into.


ISX:IRRA
84GF Score
PT Itama Ranoraya Tbk ISX:IRRA
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Itama Ranoraya Tbk (ISX:IRRA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Itama Ranoraya Tbk stock appears to be undervalued. The current stock price of Rp372.00 is trading 16.7% below its estimated GF Value™ of Rp446.71. GuruFocus considers PT Itama Ranoraya Tbk to be Modestly Undervalued.

Key valuation signals for ISX:IRRA:

  • Risk Assessment:
  • GF Value™: Rp446.71 vs. price of Rp372.00 (16.7% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the ISX:IRRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Itama Ranoraya Tbk Business Description

Address Jl. KH. Teacher Amin No. 18, ITS Tower Lt.21 Nifarro Park, Sunday market, South Jakarta, Jakarta, IDN, 12510
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. It business segment includes Vitro Diagnostic Products, Non-Electromedical Sterile Medical Devices, Electromedical Sterile Medical Devices and Other Segments. The key revenue generating segments of the company are In Vitro Diagnostic product.
84GF Score

Get the complete analysis for ISX:IRRA

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp372.00
Price
Rp446.71
GF Value